CiteFacts · FDA Drug Shortages · FDA source
Rifampin Capsule
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| Epic Pharma, LLC | Rifampin, Capsule, 150 mg (NDC 42806-801-01) | Unavailable | 08/17/2026 |
| Epic Pharma, LLC | Rifampin, Capsule, 150 mg (NDC 42806-801-30) | Available | 08/17/2026 |
| Epic Pharma, LLC | Rifampin, Capsule, 300 mg (NDC 42806-799-01) | Unavailable | 08/17/2026 |
| Epic Pharma, LLC | Rifampin, Capsule, 300 mg (NDC 42806-799-05) | Unavailable | 08/17/2026 |
| Epic Pharma, LLC | Rifampin, Capsule, 300 mg (NDC 42806-799-30) | Unavailable | 08/17/2026 |
| Epic Pharma, LLC | Rifampin, Capsule, 300 mg (NDC 42806-799-60) | Available | 08/17/2026 |
| Lupin Pharmaceuticals, Inc. | Rifampin, Capsule, 150 mg (NDC 68180-658-06) | Available | 08/18/2026 |
| Lupin Pharmaceuticals, Inc. | Rifampin, Capsule, 300 mg (NDC 68180-659-06) | Available | 08/18/2026 |
| Lupin Pharmaceuticals, Inc. | Rifampin, Capsule, 300 mg (NDC 68180-659-07) | Available | 08/18/2026 |
Source facts
Grouped generic ingredient: Rifampin Capsule · 9 package records · Latest FDA row update: 08/18/2026
Therapeutic categories: Anti-Infective
Dosage forms: Capsule
Routes: ORAL
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.